Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis.

Purpose: To estimate the prevalence of mortality among patients that develop adverse drug reactions during hospitalisation (ADRIn), to examine heterogeneity through subgroup analysis and to identify system-organ class (SOC) and their causative drugs. Methods: Two investigators searched PubMed, Googl...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 75; no. 9; pp. 1293 - 1308
Autores principales: Patel, Parvati B., Patel, Tejas K.
Formato: meta analysis research systematic review tables/charts Journal Article
Publicado: Springer Nature Sep2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138111100&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 138111100
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Sep2019
      vid: 75
      iid: 9
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        138111100
        138111100
        143962246
        138111100
        10.1007/s00228-019-02702-4
        138111100
      ppf: 1293
      ppct: 15
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis.
      aug:
        au:
          Patel, Parvati B.
          Patel, Tejas K.
        affil: Department of Pharmacology, GMERS Medical College, Gotri, 390021, Vadodara, Gujarat, India
      sug:
        subj:
          Adverse Drug Event Adverse Effects
          Hospital Mortality Etiology
          Hospital Mortality Epidemiology
          Hospitalization
          Human
          Meta Analysis
          Systematic Review
          PubMed
          Internal Medicine
          Intensive Care Units
          Intensive Care, Neonatal
          Intensive Care Units, Pediatric
          Gastrointestinal Diseases
          Risk Assessment
          Lymphatic Diseases
          Kidney Diseases
          Urologic Diseases
          Fibrinolytic Agents Adverse Effects
          Antiinflammatory Agents, Non-Steroidal Adverse Effects
          Gastrointestinal Hemorrhage Chemically Induced
          Antineoplastic Agents Adverse Effects
          Hematologic Diseases Chemically Induced
          Age Factors
      ab: Purpose: To estimate the prevalence of mortality among patients that develop adverse drug reactions during hospitalisation (ADRIn), to examine heterogeneity through subgroup analysis and to identify system-organ class (SOC) and their causative drugs. Methods: Two investigators searched PubMed, Google Scholar and related bibliography for studies reporting ADRIn-related mortality data. The primary outcome was to compute overall prevalence of fatal ADRIn (95% CI) using double arcsine method. We explored the heterogeneity (I2) in its estimation based on study design, study population and data collection methods. The secondary outcomes were the pattern of fatal reactions and their causative drugs. PROSPERO register number—CRD42018090331. Results: Out of 349 full text assessed, 48 studies satisfying the selection criteria were included. The fatal ADRIn prevalence was 0.11% (95% CI 0.06–0.18%; I2 = 93%). The fatal ADRIn prevalence ranged from 0.03% (I2 = 0%) in all ages to 0.27% (I2 = 90%) in elderly population studies. Elderly studies varied for all study characteristics. Among study wards, a higher trend of prevalence was observed in 'internal medicine and ICU' (0.46%, I2 = 51%) and 'neonatal/paediatric ward and ICU' (0.34%, I2 = 58%) studies. The commonly involved SOC were 'gastrointestinal disorders' (28.79%), 'blood and lymphatic system disorders' (19.69%) and 'renal and urinary disorders' (13.64%). Most commonly observed causative drug-fatal ADRIn pairs were antithrombotics and nonsteroidal anti-inflammatory drugs induced gastrointestinal bleeding, and antineoplastic agents induced cytopenia. Conclusion: ADRIn is an important cause of mortality. Age groups and study wards have important influence on prevalence of fatal ADRIn and its heterogeneity across studies. Few class drugs contribute to sizable proportion of ADRIn-related mortality.
      pubtype: Academic Journal
      doctype:
        meta analysis
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N